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Dysregulation of the mitochondrial fission machinery has been linked to cell death
following ischemia. Fission is largely dependent on recruitment of Dynamin-related
protein 1 (Drp1) to the receptor Mitochondrial fission factor (Mff) located on the
mitochondrial outer membrane (MOM). Drp1 is a target for SUMOylation and its
deSUMOylation, mediated by the SUMO protease SENP3, enhances the Drp1-Mff
interaction to promote cell death in an oxygen/glucose deprivation (OGD) model of
ischemia. Another interacting partner for Drp1 is the Bcl-2 family member Bcl-xL,
an important protein in cell death and survival pathways. Here we demonstrate that
preventing Drp1 SUMOylation by mutating its SUMO target lysines enhances the Drp1-
Bcl-xL interaction in vivo and in vitro. Moreover, SENP3-mediated deSUMOylation of
Drp1 promotes the Drp1-Bcl-xL interaction. Our data suggest that Mff primes Drp1
binding to Bcl-xL at the mitochondria and that Mff and Bcl-xL can interact directly,
independent of Drp1, through their transmembrane domains. Importantly, SENP3 loss in
cells subjected to OGD correlates with reduced Drp1-Bcl-xL interaction, whilst recovery
of SENP3 levels in cells subjected to reoxygenation following OGD correlates with
increased Drp1-Bcl-xL interaction. Expressing a Bcl-xL mutant with defective Drp1
binding reduces OGD plus reoxygenation-evoked cell death. Taken together, our results
indicate that SENP3-mediated deSUMOlyation promotes an Mff-primed Drp1-Bcl-xL
interaction that contributes to cell death following ischemia.
Keywords: Drp1, Bcl-xL, SENP3, Mff, SUMOylation, ischemia
INTRODUCTION
Ischemia, the restriction in blood supply to tissues, is a leading cause of death and disability.
Standard clinical treatment is to restore blood supply as soon as possible to limit infarct size and
reduce mortality. Paradoxically, however, this can cause further damage, referred to as reperfusion
injury (Hausenloy and Scorrano, 2007). The pathological consequences of ischemia/reperfusion
(I/R) injury are complex, but severely impaired mitochondrial integrity invariably precedes
cell death. A well-characterized pathway involves reactive-oxygen species and Ca2+-mediated
activation of the mitochondrial inner membrane permeability transition pore, which leads to cell
necrosis (Halestrap, 2010; Tait and Green, 2010; Landes and Martinou, 2011; Pasdois et al., 2012).
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Additionally, it is becoming increasingly clear that mitochondrial
outer membrane (MOM) proteins that regulate fission induce
cell death via either modulating mPTP opening or through
apoptotic mechanisms (Halestrap, 2009, 2010; Tait and Green,
2010; Landes and Martinou, 2011; Pasdois et al., 2012; Whelan
et al., 2012). Specifically, this involves mitochondrial fission
regulated by the cytosolic dynamin family large GTPase Drp1,
which can be recruited to the MOM by interacting with
the docking proteins Mff, MiD49, MiD51 and possibly Fis1
(Atkins et al., 2016). The recruited Drp1 molecules polymerise
in a spiral around the mitochondria and cause scission of
the mitochondria by GTP hydrolysis (Elgass et al., 2013).
Inhibition of Drp1 using the GTPase blocker dynasore (Macia
et al., 2006) or the Drp1-selective inhibitor Mdivi-1 (Cassidy-
Stone et al., 2008) can protect cells against I/R injury in vitro
and in vivo (Grohm et al., 2012; Sharp et al., 2015; Wang
et al., 2018), and reduced Drp1 localization at mitochondria
is cytoprotective (Ong et al., 2010; Grohm et al., 2012;
Din et al., 2013; Sharp et al., 2014). Thus, active Drp1
localized at mitochondria plays a key role in mediating cell
death following extreme stress, but the upstream triggers and
downstream effector systems that underpin these effects are
largely unknown.
Intriguingly, animals that hibernate endure prolonged
ischemia and subsequent reperfusion but emerge from
hibernation torpor undamaged (Andrews, 2007). This natural
phenomenon appears at least partially attributable to the
cytoprotective effects of increased SUMOylation during torpor
(Lee et al., 2007, 2012). SUMOylation is the covalent conjugation
of a Small Ubiquitin-like MOdifier protein (SUMO) to lysine
residue(s) in target proteins. Currently three conjugatable
SUMO paralogues (SUMO-1-3) have been identified in humans.
SUMO-2 and SUMO-3 are very similar, differing in only three
amino acid residues, and are therefore collectively termed
SUMO-2/3, but SUMO-1 differs from SUMO-2/3. It is generally
accepted that SUMO-1 is important for normal cell function
and maintenance, whereas, in contrast, SUMO-2/3 appears to
be essential in cell stress pathways (Guo and Henley, 2014).
In agreement with observations made in hibernating animals,
increased SUMO-2/3-lyation is readily detectable in cerebral
ischemia models (Cimarosti et al., 2008; Yang et al., 2008a,b;
Loftus et al., 2009), and microRNA-mediated knockdown of
SUMO-2/3 substantially reduces cell survival following ischemic
stress (Datwyler et al., 2011), highlighting the critical role for
SUMO-2/3 in preventing cell death.
Protein SUMOylation is reversible, and target proteins can
be deSUMOylated by a number of identified SUMO protease(s)
(Hickey et al., 2012). The largest and best characterized family
of SUMO proteases is that of the sentrin-specific proteases
(SENPs), composed of six members (SENP1–3 and 5–7) with
each having distinct deconjugation preference toward specific
SUMO paralog(s) (Hickey et al., 2012). Both SENP1 and
SENP2 have deconjugation activity for SUMO-1 and SUMO-2/3,
whereas SENP3 and SENP5 have specific activity for SUMO-2/3
deconjugation (Gong and Yeh, 2006). However, specific targets
and pathophysiological roles for SENPs in cell stress responses
are largely unknown.
In previous work we uncovered a cytoprotective pathway
in which degradation of SENP3 upon ischemia (modeled by
oxygen/glucose depravation, OGD) protects the SUMO-2/3-
ylation status of the GTPase Drp1, a well-established SUMO
target protein (Figueroa-Romero et al., 2009), reducing Drp1
localization at mitochondria to enhance cell survival (Guo et al.,
2013). However, during reoxygenation following OGD, SENP3
levels recover, reducing Drp1 SUMOylation and enhancing
Drp1 localization at mitochondria to promote cell death
(Guo et al., 2013).
Our further work revealed that SENP3-mediated
deSUMOylation selectively enhances Drp1 interaction
with the docking protein Mff, thereby promoting Drp1
mitochondrial localization and eventually contributing to
cell death evoked by reoxygenation following OGD (Guo
et al., 2017). These results highlight that SENP-mediated
deSUMOylation is a regulator of protein-protein interactions
that can significant impact on cellular processes, including
mitochondrial dynamics and cell death.
Interestingly, in addition to its association with Mff, Drp1 also
binds the Bcl-2 family member Bcl-xL (Jonas, 2014). The Drp1-
Bcl-xL interaction appears to be important for synaptogenesis
(Li et al., 2008) and modulation of neurotransmitter vesicle
endocytosis in cultured primary rat hippocampal neurons (Li
et al., 2013). However, it is unknown whether SENP3-mediated
deSUMOylation regulates the Drp1-Bcl-xL interaction, and
whether this interaction has a role in cell death and survival
pathways (Michels et al., 2013).
Here, using deletion mutagenesis and amino acid
substitution approaches in our established ischemia model,
we systematically explored the impact of changes in Drp1
SUMOylation on the Drp1-Bcl-xL interaction, and the
roles of the deSUMOylating enzyme SENP3 and Mff in
regulating the Drp1-Bcl-xL interaction. We examined the
dynamic changes in the Drp1-Bcl-xL interaction following
ischemia and assessed the functional consequence of the




DNA constructs encoding Flag-SENP3, GST-Mff, GST-Mff
1N50, YFP-Drp1, YFP-Drp1R, YFP-Drp1 4KR, YFP-Drp1R 4KR,
and YFP-Drp1R115 have been described previously (Guo et al.,
2013, 2017). Drp1-His was provided by M. Matsushita (Han
et al., 2008). Drp1115-His wasmade by PCR-basedmutagenesis.
Flag-Mff was generated by insertion of the relevant cDNA into
the BamH1/Not1 sites of pcDNA3-Flag. GST-Mff 1C deletion
mutant (residues 1–322) was generated by insertion of the
relevant cDNA into the BamH1/Not1 sites of pEBG. GST-Mff
1RR (residues 1–340) was generated by PCR-based mutagenesis
to remove the DNA sequence encoding the final two residues
(R341 and R342) at the C-terminus of Mff. RFP-Mff TM was
generated by PCR-based mutagenesis to fuse the cDNA sequence
encoding the Mff TM (residues 323–340) to the C-terminus of
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RFP immediately before the stop codon (TAA) in pcDNA3-
RFP (Addgene Plasmid #13032; provided by D. Golenbock).
Mammalian expression DNA constructs encoding HA-Bcl-xL
and E. coli expression construct (pTXB1) encoding Bcl-xL, were
provided by D. R. Green (Llambi et al., 2011). Bcl-xL-YFP
was generated by PCR-based insertion of the relevant cDNA
into the EcoRI/NotI sites of pcDNA3-YFP (Addgene Plasmid
#13033; provided by D. Golenbock) (Guo et al., 2017). Bcl-xL
1C deletion mutant-YFP (residues 1–211), Bcl-xL 1C7 deletion
mutant-YFP (residues 1–226), and Bcl-xL 1N deletion mutant-
YFP (lacking residues 2–76) were generated by insertion of
the relevant cDNAs into the EcoRI/NotI sites of pcDNA3-
YFP, respectively. YFP-Bcl-xL TM was generated by PCR-based
mutagenesis to fuse the cDNA sequence encoding Bcl-xL TM
(residues 210–226) to the C-terminus of YFP immediately before
the stop codon (TAA) in pcDNA3-YFP. Bcl-xL M2 (mutant)-YFP
was generated by PCR-based mutagenesis to mutate the DNA
sequence encoding three residues (W188S, D189V, and F191C)
in the BH2 domain of Bcl-xL using a pair of primers as previously
described (Li et al., 2013).
Protein Expression and Purification and
Histidine Pulldown-Based Binding Assay
Bcl-xL was first purified from the vector pTXB1 using E. coli
BL21 Star (DE3) cells as a fusion protein with intein/chitin-
binding domain using a chitin resin, and Bcl-xL was then cleaved
from the resin in a buffer containing 20 mM Tris pH 8.0,
0.5 M NaCl, 1 mM EDTA, protease inhibitors (Roche), and
50 mM DTT for 48 h using IMPACTTM Kit (New England
Biolabs) as described previously (Llambi et al., 2011). Drp1
WT-His or Drp1 115-His mutant were produced from the
vector pET21a using E coli BL21 Star (DE3) cells (Invitrogen)
as described previously (Guo et al., 2017) and purified on Ni2+-
NTA beads (Qiagen). To detect the physical interaction between
Bcl-xL and Drp1, an in vitro binding assay was performed.
Briefly, equal amount of Bcl-xL were incubated with Ni
2+-
NTA beads or Ni2+-NTA beads bound with His-tagged Drp1
WT or 115 mutant in a binding buffer containing 10 mM
HEPES, 1 mM EDTA (pH 7.4), 150 mM NaCl, on a rotating
platform for 1 h at 4◦C. At the end of the incubation, the
beads were spun down, washed three times with a buffer
containing 10 mMHEPES, 1 mM EDTA (pH 7.4), 150 mMNaCl
plus 0.2% CHAPS, and resuspended in SDS sample buffer for
immunoblot analysis.
Cell Culture
HEK293 cells were grown in Dulbecco’s modified Eagle’s medium
(Lonza) containing 10% fetal bovine serum, 5 mM glutamine,
and 100 units/ml penicillin/streptomycin at 37◦C in humidified
ambient air supplemented with 5% CO2 as described previously
(Guo et al., 2013, 2017).
DNA and siRNA Transfections
DNA, siRNA, or DNA & siRNA were transfected into
HEK293 cells using jetPRIME (Polyplus Transfection).
siRNA duplexes used were as follows: human SENP3
siRNA (Santa Cruz, sc-44451) and human Bcl-xL-
specific siRNA (Eurofins MWG Operon; target sequence
GCGUAGACAAGGAGAUGC).
Subcellular Fractionation
Mitochondrial and cytosolic fractions from HEK293 cells were
prepared as described previously (Guo et al., 2013, 2017).
Oxygen-Glucose Deprivation and
Reoxygenation
OGD was conducted within a SCI-tive hypoxia workstation
(Baker Ruskinn) under the settings of 0.1% O2 and 5% CO2
at 37◦C. Briefly, DMEM without glucose containing 0.1% FBS
(Invitrogen) and 5 mM glutamine was deoxygenated for 2 h
within the hypoxia workstation. HEK293 cells were then washed
with the deoxygenated DMEM, and the cells were replaced with
the medium and maintained in the hypoxia workstation for
2 h. In parallel, normal culture medium was removed from
control cells, the cells were washed with fresh DMEM containing
glucose, 0.1% FBS, and 5 mM glutamine, and replaced with the
medium and maintained in a normoxic cell culture incubator.
For reoxygenation experiments HEK293 cells were moved from
the hypoxia workstation and kept at 37◦C in humidified ambient
air supplemented with 5% CO2 for a further 24 h.
Lactate Dehydrogenase (LDH) Assay
Lactate dehydrogenase (LDH) levels in conditioned culture
media were examined using a Lactic Dehydrogenase Based In
Vitro Toxicology Assay Kit (Sigma) as described previously
(Guo et al., 2013, 2017). Values presented in each histogram
are representative of at least three independent experiments
conducted using different cell populations.
Preparation of Whole Cell Lysates,
Y/RFP-Trap, SUMO-2/3-Trap,
GST-Pulldown, and Immunoprecipitation
Whole cell lysates were prepared by lysing cells with a buffer
containing 20 mM Tris, pH 7.4, 137 mM NaCl, 25 mM β-
glycerophosphate, 2 mM sodium pyrophosphate, 2 mM EDTA,
1% Triton X-100, 0.1% SDS, 10% glycerol, and 1 × protease
inhibitor cocktail (Roche).Whole cell lysates were incubated with
GFP-Trap-A beads or RFP-Trap Agarose beads (ChromoTek) to
enrich and isolate Y/RFP or Y/RFP-tagged proteins as described
previously (Guo et al., 2017). Whole cell lysates were incubated
with SUMO-2/3 affinity agarose beads (ASM24; Cytoskeleton) at
4◦C for overnight to enrich and isolate SUMO-2/3 or SUMO-2/3
conjugates. Whole cell lysates were incubated with glutathione-
sepharose 4B beads (Generon) to enrich and isolate GST or
GST-tagged proteins as described previously (Guo et al., 2017).
To immunoprecipate endogenousMff, Bcl-xL or Drp1, whole cell
lysates were incubated overnight with an Mff rabbit polyclonal
antibody (17090-1-AP, Proteintech), a Bcl-xL rabbit monoclonal
antibody (54H6, Cell Signaling) or a Drp1 rabbit monoclonal
antibody (D6C7, Cell Signaling), pre-conjugated to protein-A
beads (Sigma), respectively. The protein-A beads were spun
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FIGURE 1 | Changes in the SUMOylation status of Drp1 regulate its interaction with Bcl-xL. (A) Ablation of Drp1 SUMOylation results in increased interaction
between Drp1 and Bcl-xL. YFP, YFP-Drp1 WT or YFP-Drp1 4KR mutant were introduced into HEK293 cells. Lysates were subjected to pulldown using YFP-Trap for
YFP or YFP-Drp1. YFP-Trap and lysate samples were immunoblotted with Bcl-xL, GFP, and β-actin antibodies (n = 3; *p < 0.05). (B) Ablation of SUMOylation in Drp1
results in increased colocalization with endogenous Bcl-xL. Either YFP-Drp1
R wild type (WT) or non-SUMOylatable Drp1R 4KR mutant were introduced into HeLa
cells following knockdown of endogenous Drp1 (n = 29 cells for Drp1i+ YFP-Drp1R WT and n = 26 cells for Drp1i+ YFP-Drp1R 4KR; ***p < 0.001). (C) Immunoblots
(lower panel) confirm knockdown of Drp1 and replacement of YFP-Drp1R WT or 4KR mutant in HeLa cells (Nsi, Non-specific siRNA; Drp1i, Drp1 siRNA).
down, washed three times and resuspended in SDS sample buffer
for immunoblot analysis.
Immunoblotting
Samples were resolved by SDS-PAGE (10–15% gels), transferred
to Immobilon-Pmembranes (Millipore Inc.) and immunoblotted
as indicated. Primary antibodies were used to detect Bcl-xL
(54H6, 1:1,000 dilution, Cell Signaling; 2H12, 1:500 dilution,
Invitrogen), COX IV (3E11, 1:20,000 dilution, Cell Signaling),
Drp1 (D6C7, 1:1,000 dilution, Cell Signaling), Flag (66008-3-Ig,
1:1,000 dilution, Proteintech), GAPDH (sc-365062, 1:1,000
dilution, Santa Cruz biotechnology), GFP (sc-8334, 1:1,000
dilution, Santa Cruz biotechnology), HA (51064-2-AP, 1:1,000
dilution, Proteintech), Mff (17090-1-AP, 1:2,000 dilution,
Proteintech), PARP (46D11; 1:1,000 dilution, Cell Signaling),
RFP (3F5, 1:1,000 dilution, ChromoTek), SENP3 (D20A10,
1:10,000 dilution, Cell Signaling), and β-actin (A2228, 1:20,000
dilution, Sigma). Immune complexes were detected either using
HRP-conjugated secondary antibodies (Sigma) or an HRP-
conjugated VeriBlot secondary antibody (ab131366, Abcam; for
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FIGURE 2 | The sequence containing the SUMOylation sites of Drp1 is important for the Bcl-xL-Drp1 interaction. (A) The schematic illustrates a Drp1 mutant in
which a 15-residue sequence containing 4 SUMOylatable lysines within the variable region was removed. (B) Removal of the SUMOylated region in Drp1 results in
decreased interaction between Drp1 and Bcl-xL in vivo. YFP-Drp1 WT, Drp1 4KR, or Drp1 115 were expressed in HEK293 cells. YFP-Trap and lysate samples were
immunoblotted with Bcl-xL, GFP, and β-actin antibodies. (C) Removal of the SUMOylatable region in Drp1 results in decreased interaction between Drp1 and Bcl-xL
in vitro. His-tagged Drp1 or His-tagged Drp1 115 were incubated with Bcl-xL in vitro. Bcl-xL associated with Drp1-His was detected using immunoblotting following
His-pulldown (n = 3; *p < 0.05).
immunoblotting involving IP samples) followed by enhanced
chemiluminescence (GE Healthcare Amersham), or using
fluorescent secondary antibodies (Thermo Fisher Scientific)
by a LI-COR imaging system. Each immunoblot presented is
representative of at least three independent experiments carried
out using different cell populations.
Cell Imaging Assay
Cells were fixed for 12 min at room temperature using 4%
paraformladehyde/PBS with 5% sucrose. Cell imaging was
performed as previously described (Guo et al., 2013).
Statistics
Graph plotting and statistical analysis were conducted
using Graphpad Prism software (Graphpad Inc.). A two-
tailed paired Student’s t-test was used for comparisons
between two data sets, and one-way analysis of variance
followed by Tukey’s multiple comparisons test was used for
comparison of multiple data sets. All values are expressed
as mean ± SEM following the normalization in relation to
the control level.
RESULTS
The SUMOylation Status of Drp1
Regulates the Drp1-Bcl-xL Interaction
In agreement with previous reports (Li et al., 2013, 2008),
we detected an interaction between Bcl-xL and Drp1
(Figure 1A and Supplementary Figure 1). Interestingly,
compared to wild type (WT), non−SUMOylatable Drp1
4KR mutant shows significantly enhanced association
with Bcl-xL (Figure 1A), suggesting that preventing
Drp1 SUMOylation promotes its interaction with Bcl-xL.
Consistent with our biochemical results, imaging analysis
revealed significantly increased co-localization between
RNAi-resistant non−SUMOylatable Drp1 4KR mutant
and Bcl-xL in Drp1 knockdown HeLa cells, compared
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to WT Drp1 (Figures 1B,C). Collectively, these results
indicate that the Drp1-Bcl-xL interaction is regulated by
the SUMOylation status of Drp1.
Bcl-xL Binds Directly to Drp1
SUMOylation of Drp1 occurs within a conserved sequence of
15 amino acid residues containing four target lysines required
for SUMO conjugation located in the variable region (VR)
(Figure 2A; Guo et al., 2017), which is crucial for mitochondrial
localization of this large GTPase (Fröhlich et al., 2013). We
reasoned that, if this VR sequence is the interface between
Drp1 and Bcl-xL, modification by SUMO might sterically
hinder this protein-protein interaction. Moreover, removing
this 15 residue sequence altogether (Drp1115 mutant) may
prevent Bcl-xL binding to Drp1. As expected, endogenous Bcl-
xL did not associate with the Drp1115 mutant (Figure 2B),
indicating the importance of this sequence for Drp1-Bcl-
xL association and suggesting that fully SUMOylation of
Drp1 may completely prevent Drp1 association with Bcl-xL.
Previous studies have not identified whether the Drp1-Bcl-
xL interaction results from the direct interaction of the two
proteins (Li et al., 2008, 2013). We therefore performed in vitro
binding assays, which demonstrated the physical interaction
between Bcl-xL and Drp1, and that the Drp1115 mutant no
longer interacts with Bcl-xL (Figure 2C). Collectively, these
results suggest that although direct binding of Bcl-xL to Drp1
needs the sequence containing the SUMO conjugation sites
in Drp1, SUMO modification of one or more of the lysines
within this stretch of amino acid downregulates the Bcl-xL-
Drp1 interaction.
SENP3 Promotes the Bcl-xL-Drp1
Interaction
Drp1 is deSUMOylated by SENP3 (Guo et al., 2013, 2017).
Therefore, we investigated if SENP3 regulates the Bcl-xL-Drp1
interaction. As expected, overexpression of SENP3 enhances Bcl-
xL interaction with Drp1 WT, but not non-SUMOylatable Drp1
in HEK293 cells (Figure 3A). In contrast, SENP3 knockdown
reduces Bcl-xL interaction with YFP-Drp1 overexpressed in
HEK293 cells (Figure 3B). These data indicate that SENP3-
mediated deSUMOylation of Drp1 promotes Drp1-Bcl-xL
complex formation.
Mitochondrial Fission Factor Primes the
Drp1-Bcl-xL Interaction at Mitochondria
We have reported previously that the non−SUMOylatable
Drp1 4KR mutant associates more with mitochondria
than Drp1-WT (Guo et al., 2013). Consistent with those
data subcellular fractionation and immunoblotting further
revealed the mitochondria as a major subcellular location
for the non-SUMOylatable Drp1 and Bcl-xL interaction
(Figure 4A). These results suggest an involvement of
deSUMOylation-mediated Drp1 mitochondrial recruitment
in regulating the Drp1-Bcl-xL interaction. Mff is the major
docking protein for Drp1 on the MOM (Otera et al.,
2010) and Drp1 SUMOylation regulates mitochondrial
recruitment by Mff (Guo et al., 2017). Moreover, Mff is
also associated with Bcl-xL in rat brain tissue (Li et al.,
2013). We therefore investigated if the expression level of
Mff is a regulatory factor for the Drp1-Bcl-xL interaction.
Mff knockdown decreased the interaction between non-
SUMOylatable Drp1 and Bcl-xL whereas Mff overexpression
increased this interaction (Figures 4B,C). As expected, Bcl-
xL knockdown did not affect the binding between GST-Mff
and Drp1, excluding a role for Bcl-xL in recruiting Drp1 to
the mitochondria through Mff (Figure 4D). These results
suggest that Mff primes the interaction between Drp1 and
Bcl-xL most likely through recruiting non-SUMOylated
Drp1 to the mitochondria, thus increasing its proximity to
mitochondrial Bcl-xL.
Mff and Bcl-xL Directly Interact With
Each Other Through Their
Transmembrane Domains in a
Drp1-Independent Manner
An endogenous complex of Mff/Drp1/Bcl-xL has been detected
biochemically, and interactions betweenMff/Drp1 andDrp1/Bcl-
xL are well established (Li et al., 2008, 2013; Otera et al.,
2010; Guo et al., 2017). Therefore, we investigated if Mff can
bind directly to Bcl-xL. Interestingly, Bcl-xL was associated
with GST-Mff in HEK293 cells, and this association was not
affected by Drp1 depletion by RNAi-mediated knockdown,
suggesting Mff and Bcl-xL may interact independently of Drp1
(Figure 5A). Next, we examined the interfaces involved in Mff-
Bcl-xL interactions. The first 50 amino acid residues at the
N-terminus of Mff, which mediate recruitment of Drp1 to the
mitochondria (Otera et al., 2010), are not important for binding
of GST-Mff to Bcl-xL (Supplementary Figure 2). In contrast,
removal of the last 20 amino acids of Mff, containing the
transmembrane domain (TM of 18 residues), plus 2 C-terminal
residues located in the mitochondrial intermembrane space
(IMS), abolished the binding of the two proteins. Deletion of
only the 2 IMS residues increased the binding of GST-Mff to
Bcl-xL (Figure 5B), suggesting that the Mff TM is essential
for the Mff-Bcl-xL interaction and that the presence of two
IMS-located residues may inhibit this interaction through an
unknown mechanism. Indeed, RFP-Mff TM interacts with Bcl-
xL (Figure 5C), confirming the importance of the Mff TM in
mediating the Mff-Bcl-xL interaction. Likewise, removal of the
last 22 amino acid residues of Bcl-xL, containing most of the
TM domain (15 residues of TM) plus 7 residues present in the
IMS, abolished binding between the two proteins. Deletion of the
7 IMS residues did not alter the binding of Bcl-xL-YFP to Mff
(Figure 5D), suggesting that the TM of Bcl-xL is also important
for the Mff-Bcl-xL interaction. Indeed, YFP-Bcl-xL TM interacts
with Mff (Figure 5E), confirming the importance of the Bcl-xL
TM in mediating the Mff-Bcl-xL interaction. Furthermore, the
TMs of both proteins interacted with each other (Figure 5F).
Finally, we detected endogenous association between Mff and
Bcl-xL in untreated HEK293 cells (Figure 5G). These results
demonstrate a TM-mediated interaction between Mff and Bcl-xL
which occurs independently of Drp1.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 October 2021 | Volume 9 | Article 752260
Guo et al. Bcl-xL in SENP3-Mediated Cell Death
FIGURE 3 | SENP3 promotes the Drp1-Bcl-xL interaction. (A) Overexpression of SENP3 increases the interaction between Drp1 and Bcl-xL. Either pcDNA3 or
Flag-SENP3 together with a construct expressing either YFP-Drp1 WT or YFP-Drp1 4KR mutant were transfected into HEK293 cells. YFP-Trap and lysate samples
were immunoblotted with Bcl-xL, GFP, and β-actin antibodies. (B) Knockdown of SENP3 decreases the interaction between Drp1 and Bcl-xL. Either Nsi or SENP3
siRNA together with a construct expressing either YFP-Drp1 or YFP-Drp1 4KR mutant were introduced into HEK293 cells. YFP-Trap and lysate samples were
immunoblotted with Bcl-xL, GFP, and β-actin antibodies.
FIGURE 4 | Mff primes the binding of Drp1 to Bcl-xL on the mitochondria. (A) Drp1 mainly interacts with Bcl-xL at mitochondria. YFP-Drp1 4KR mutant was
transfected into HEK293 cells. YFP-Drp1 4KR mutant was pulled down from the cytosolic fraction or mitochondrial fraction using YFP-Trap. YFP-Trap and
subcellular fraction samples were immunoblotted with Bcl-xL, GFP, GAPDH and COX IV antibodies. Removal of unrelated lanes are indicated by dotted lines. (B) Mff
knockdown decreases the interaction between Bcl-xL and Drp1. Nsi or Mff siRNA (Mffi) were transfected into HEK293 cells expressing the YFP-Drp1 4KR mutant.
YFP-Trap and lysate samples were immunoblotted with Bcl-xL, GFP, Mff, and β-actin antibodies. (C) Mff overexpression increases the interaction between Bcl-xL
and Drp1. Flag-Mff was transfected into HEK293 cells expressing the YFP-Drp1 4KR mutant. YFP-Trap and lysate samples were immunoblotted with Bcl-xL, Flag,
GFP, and β-actin antibodies. (D) Bcl-xL knockdown does not affect the interaction between Mff and Drp1. Nsi or Bcl-xL siRNA (Bcl-xL i) were transfected into
HEK293 cells expressing GST or GST-Mff. GST-pulldown (GST-PD) and lysate samples were immunoblotted with Drp1, GST, Bcl-xL, and β-actin antibodies.
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FIGURE 5 | Mff and Bcl-xL interact through their C-terminal transmembrane domains in a manner independent of Drp1. (A) Drp1 knockdown does not affect the
interaction between Mff and Bcl-xL. Either Nsi or Drp1i were introduced into HEK293 cells expressing either GST or GST-Mff. GST-Pulldown (GST-PD) and lysate
samples were immunoblotted with Bcl-xL, Drp1, GST, and β-actin antibodies. (B) The transmembrane domain (TM) of Mff is important for its interaction with Bcl-xL.
GST, GST-Mff, GST-Mff 1C, or GST-Mff 1RR were transfected into HEK293 cells. GST-PD and lysate samples were immunoblotted with Bcl-xL, Drp1, GST, and
β-actin antibodies. The schematics illustrate domain structures for Mff and Mff deletion mutants (Upper panel). (C) Mff TM interacts with Bcl-xL. RFP or RFP-Mff TM
were transfected into HEK293 cells. RFP-Trap and lysate samples were immunoblotted with Bcl-xL, RFP, and β-actin antibodies. (D) Bcl-xL TM is important for its
interaction with Mff. The schematics illustrate domain structures for Bcl-xL, Bcl-xL 1C mutant and Bcl-xL 1C7 mutant (Upper panel). YFP, Bcl-xL-YFP, or Bcl-xL-YFP
1C were transfected into HEK293 cells (Middle panel). YFP, Bcl-xL-YFP, or Bcl-xL-YFP 1C7 were transfected into HEK293 cells (Lower panel). YFP-Trap and lysate
samples were immunoblotted with Mff, GFP, and β-actin antibodies. (E) Bcl-xL TM interacts with Mff. YFP or YFP-Bcl-xL TM were transfected into HEK293 cells.
YFP-Trap and lysate samples were immunoblotted with Bcl-xL, GFP, and β-actin antibodies. (F) Bcl-xL TM and Mff TM interact. RFP or RFP-Mff TM were transfected
in HEK293 expressing YFP or YFP-Bcl-xL TM. YFP-Trap (Upper panel) or RFP-Trap (Lower panel) and lysate samples were immunoblotted with RFP, GFP, and
β-actin antibodies. (G) Endogenous Mff is associated with endogenous Bcl-xL. Bcl-xL was immunoprecipitated from whole cell lysates prepared from HEK293 cells
using an Mff antibody. IP and lysate samples were immunoblotted with Mff, Bcl-xL, and β-actin antibodies.
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Effects of Cell Stress on Drp1
Recruitment in HEK293 Cells
We have previously reported that in cultured primary neurons
metabolic stress caused by oxygen-glucose deprivation (OGD)
cause a reduction in SENP3 levels that enhances Drp1
SUMOylation by SUMO-2/3, leading to Drp1 partitioning away
from mitochondria (Guo et al., 2013). However, OGD plus
reoxygenation promoted SENP3 recovery, Drp1 deSUMO-2/3-
ylation, Drp1 recruitment to mitochondria and consequent loss
of mitochondrial integrity (Guo et al., 2013). Consistent with
those results, here we show that OGDplus reoxygenation reduced
Drp1 deSUMO-2/3-ylation beneath control levels in HEK293
cells (Supplementary Figure 3). Taken together, our previous
finding that SENP3-mediated deSUMOylation enhances Drp1
mitochondrial recruitment through selectively promoting the
Drp1-Mff interaction (Guo et al., 2017) and that a region in
BH2 domain of Bcl-xL is essential for its interaction with Drp1
(Li et al., 2013), we propose a model (Figure 6) whereby
an Mff-primed Drp1-Bcl-xL interaction is regulated by the
SUMOylation status of Drp1.
Oxygen-Glucose Deprivation Reduces
the Drp1-Bcl-xL Interaction While
Oxygen-Glucose Deprivation Plus
Reoxygenation Enhances It
To interrogate this proposal further, we investigated if OGD-
induced changes on SENP3 levels impact on the endogenous
association of Bcl-xL-Drp1. Indeed, while Drp1 associated with
Bcl-xL in unstressed cells (Figure 7A and Supplementary
Figure 4), this association was greatly reduced in cells subjected
to OGD alone (Figure 7B). In contrast, the association between
the two proteins was markedly enhanced in reoxygenated cells
after OGD (Figures 7C,D). Importantly, SENP3 knockdown
in reoxygenated cells after OGD reduced the Bcl-xL-Drp1
interaction (Figure 7E). Collectively these results suggest
that alterations in SENP3 levels, and consequent changes to
the SUMOylation status of Drp1, regulate the Bcl-xL-Drp1
association following ischemic insult.
The Drp1-Bcl-xL Interaction Promotes
Cell Death Following Reoxygenation
To examine the role for the Drp1-Bcl-xL interaction in OGD
plus reoxygenation-evoked LDH release, a marker for cell death,
we used a Bcl-xL W188S/D189V/F191C mutant (Li et al., 2013)
that does not bind Drp1 (Figure 8A). Expressing this Drp1
binding-defective Bcl-xL mutant, but not the WT counterpart,
significantly reduced OGD plus reoxygenation-evoked LDH
release by ∼22% (Figure 8B), indicating a contributory role for
the Drp1-Bcl-xL interaction in cell death following ischemia. We
have previously shown that SENP3 and Drp1 act in the same
pathway to promote cell death following ischemia. Knockdown
of either protein reduces OGD plus reoxygenation-evoked LDH
release, and knockdown of both proteins has no additive
protective effect (Guo et al., 2013). Therefore, we investigated the
effects of knocking down either SENP3 or Bcl-xL, or both in cells
FIGURE 6 | Schematics of hypothetical models show the Mff-primed
Bcl-xL-Drp1 interaction regulated by the SUMOylation status of Drp1. In these
hypothetical models, Mff recruits self-associated (dimeric and/or tetrameric)
Drp1 to the mitochondrial outer membrane (MOM), bringing Drp1 in close
proximity to Bcl-xL, which also interacts with the Mff TM through its
C-terminus, thereby priming the Bcl-xL-Drp1 interaction. (A) SUMOylation
decreases Drp1 availability on the MOM via reducing Mff-mediated
recruitment, and also reduces the direct interaction between Bcl-xL and Drp1.
(B) deSUMOylation increases Drp1 availability on the MOM via promoting
Mff-mediated recruitment, and also enhances the direct interaction between
Bcl-xL and Drp1.
later subjected to reoxygenation following OGD. Consistent with
our previous findings (Guo et al., 2013, 2017), SENP3 knockdown
is cytoprotective for cells subjected to OGD plus reoxygenation
as evidenced by significantly decreased LDH levels and decreased
cleaved PARP levels (a marker for caspase-dependent apoptosis)
(Figure 8C). Bcl-xL knockdown also significantly reduced OGD
plus reoxygenation-evoked LDH release by ∼24%, indicating a
pro-death role for this Bcl-2 family member in this in vitromodel
of ischemia (Figure 8C).
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FIGURE 7 | Exposure of cells to OGD or OGD plus reoxygenation results in changes in the Drp1-Bcl-xL association. (A) Endogenous Bcl-xL is associated with
endogenous Drp1. Bcl-xL was immunoprecipitated from whole cell lysates prepared from HEK293 cells using a Bcl-xL antibody. IP and lysate samples were
immunoblotted with Drp1, Bcl-xL, and β-actin antibodies. (B) Exposure of cells to OGD results in decreased association between Bcl-xL and Drp1. HEK293 cells
were subjected to OGD for 2 h. At the end of OGD the cells were harvested and lysates were immunoprecipitated for Bcl-xL. (C) Exposure of cells to OGD plus
reoxygenation results in increased association between Bcl-xL and Drp1. HEK293 cells were subjected to OGD for 2 h followed by 24 h reoxygenation. At the end of
reoxygenation the cells were harvested and lysates were immunoprecipitated for Bcl-xL. Removal of unrelated lanes indicated by dotted lines. (D) Exposure of cells
to OGD plus reoxygenation results in increased association between Bcl-xL and Drp1. HEK293 cells were subjected to OGD for 2 h followed by 24 h reoxygenation.
At the end of reoxygenation the cells were harvested and lysates were immunoprecipitated for Drp1. (E) SENP3 knockdown reduces the association between Bcl-xL
and Drp1 induced by OGD plus reoxygenation. HEK293 cells were transfected with Nsi or SENP3i for 48 h before being subjected to OGD for 2 h followed by 24 h
reoxygenation. At the end of reoxygenation the cells were harvested and lysates were immunoprecipitated for Bcl-xL. In (B–E) IP and lysate samples were
immunoblotted with Drp1, Bcl-xL, SENP3, GAPDH and β-actin antibodies.
Interestingly, knockdown of either SENP3 or Bcl-xL abolished
the protective effects observed upon the knockdown of either
protein (Figure 8C), suggesting that SENP3 and Bcl-xL both have
required roles in cell death following reoxygenation. Bcl-xL may
act in other pathway(s) in conjunction with, or in parallel with,
the pathway controlled by SENP3-mediated deSUMOylation of
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FIGURE 8 | The Drp1-Bcl-xL interaction contributes to cell death following reoxygenation. (A) The Bcl-xL M2 mutant does not interact with endogenous Drp1. YFP,
Bcl-xL-YFP or Bcl-xL M2 (mutant)-YFP were transfected into HEK293 cells. YFP-Trap and lysate samples were immunoblotted with Drp1, GFP, and β-actin
antibodies. (B) Expression of Bcl-xL M2-YFP decreases OGD plus reoxygenation-evoked LDH release. Immunoblots (lower panel) show expression of YFP,
Bcl-xL-YFP or Bcl-xL-YFP M2 mutant in HEK293 cells subjected to OGD plus reoxygenation and cleaved PARP in these cells. (C) Bcl-xL knockdown reduces OGD
plus reoxygenation-evoked LDH release in the presence of SENP3 but not in the absence of SENP3. Immunoblots (lower panel) show knockdown of SENP3 and/or
Bcl-xL in HEK293 cells subjected to OGD plus reoxygenation and cleaved PARP in these cells. In (B,C) values are presented as mean ± SEM in the histogram
(n = 4∼6 replicates for each group; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).
Drp1. Collectively, these results indicate that the Drp1-Bcl-xL
interaction promotes cell death following reoxygenation after
OGD and suggest that Bcl-xL has additional role(s) in regulating
cell death through unknown mechanism(s).
DISCUSSION
There is a wealth of evidence that SUMOlyation can play a central
role in cytoprotection (for review see Guo and Henley, 2014),
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but the specific components in these adaptive cell responses
remain largely unidentified. In this study, we report that Drp1
SUMOylation regulates the interaction between Drp1 and Bcl-
xL that contributes to the loss of mitochondrial viability and cell
death evoked by reoxygenation following OGD.
Mff is the major docking protein for Drp1 recruitment to the
MOM. Our data demonstrate endogenous association between
the transmembrane domains of Mff and Bcl-xL. Our results are
consistent with a stoichiometric ratio of 1:1 at mitochondria
for exogenously expressed Mff and Bcl-xL reported previously
using fluorescence resonance energy transfer two-hybrid analysis
(Ma et al., 2019). Moreover, our findings suggest the Mff-Bcl-xL
interaction may serve as a scaffolding complex for facilitating the
Drp1-Bcl-xL interaction.
We find that SENP3 promotes the Drp1-Bcl-xL interaction
through at least two mechanisms: (i) an indirect pathway
where SENP3-mediated deSUMOylation leads to increased
mitochondrial recruitment of Drp1 through enhanced Drp1-Mff
interaction, and (ii) a direct pathway where SENP3-mediated
deSUMOylation facilitates the Drp1-Bcl-xL interaction.
Furthermore, in addition to Bcl-xL localized in the
mitochondria through its TM domain, the Bcl-2 protein is
also present in the cytosol (Edlich et al., 2011). Because the
binding site for Bcl-xL to Drp1 is outside the TM domain, the
cytosolic Bcl-xL may also interact with Drp1 and this may also be
facilitated by SENP3-mediated deSUMOylation. For example, a
Drp1-Bcl-xL interaction has been detected in the synaptic vesicles
of cultured rat hippocampal neurons where non-mitochondrial
Mff is responsible for recruiting Drp1 to synaptic vesicles
through an unidentified mechanism (Li et al., 2008, 2013).
Therefore, it is tempting to speculate that SENP3 might have a
role in the regulation of Drp1-Bcl-xL-mediated synaptic vesicle
membrane dynamics during endocytosis in neurons.
We note that in the present study that although SENP3
recovered to control levels in cells subjected to reoxygenation
after OGD the Drp1-Bcl-xL interaction remained enhanced.
Based on our experimental evidence presented in this study
showing that (i) SENP3 levels return to approximately
control levels (Figures 7C,D), and (ii) Drp1 SUMO-2/3-
ylation levels actually decrease beneath control levels
(Supplementary Figure 3), in the reoxygenationed cells
after OGD, there are two scenarios to be further explored
in our future investigation: (i) recovered SENP3 upon
reoxygenation is more active in deSUMO-2/3-ylating Drp1,
and (ii) other factors resulting in decreased SUMO-2/3-
conjugation upon reoxygenation contribute to this reduction
of Drp1 SUMO-2/3-ylation. Thus, a tenable explanation for
this observation might be that the recovery of SENP3, in
addition to possible other factors, leads to a “rebound” in
Drp1 SUMOylation beneath control levels, leading to enhanced
Drp1-Bcl-xL interaction.
Interestingly, we find that RNAi-mediated depletion
of Bcl-xL reduces cell death evoked by OGD plus
reoxygenation. This indicates that Bcl-xL plays an overall
pro-cell death role in our OGD/reoxygenation model.
Two possibilities have been considered. First, Bcl-xL
is normally anti-apoptotic but cleavage or occlusion
of the N-terminus could transform it into a pro-cell
death fragment that acts like pro-cell death protein Bax
(Jonas et al., 2004). However, if this were the case in our
OGD/reoxygenation model, a Bcl-xL cleavage fragment
of ∼6∼8 kDa would be expected. We were unable to
detect any such cleavage product using an N-terminal
directed rabbit monoclonal antibody for Bcl-xL (54H6;
Cell Signaling) (Supplementary Figure 5). Moreover,
expressing YFP-tagged Bcl-xL lacking amino acids 2–
76 did not cause changes in either cleaved PARP levels
or LDH release levels in HEK293 cells subjected to
OGD plus reoxygenation (Supplementary Figure 6).
Nevertheless, in future studies it may be necessary to
perform other methods, such as mass spectrometry, to further
address the question of whether Bcl-x cleavage occurs in
this model system.
A second possibility is that the Drp1-Bcl-xL interaction
or additional protein(s) binding to the complex may cause
conformational changes in Bcl-xL and turn it into a pro-
cell death factor. It has been reported previously that
conformational changes of Bcl-xL can be induced by its
association with Bcl-2 homology 3 (BH3)-only Protein
p53 Up-regulated Modulator of Apoptosis (PUMA) (Follis
et al., 2013), which appears to mediate mitochondrial
localization of Drp1 upon I/R injury (Din et al., 2013). It
would be very interesting to investigate in future if PUMA
involvement underlies the Bcl-xL pro-cell death effect
revealed in this study.
Intriguingly, we found that Bcl-xL depletion has a similar
effect to expressing a Drp1-binding defective Bcl-xL mutant
in cells subjected to OGD plus reoxygenation, suggesting
that loss of the Drp1-Bcl-xL interaction following Bcl-xL
depletion might result in this cytoprotective effect. However,
it should be noted that Bcl-xL plays fundamental roles in
controlling multiple cellular functions including regulation of
cell death and survival, autophagy, maintenance of homeostatic
metabolism, and coordination of adaptive responses to stress,
via innumerable mechanisms (Michels et al., 2013). Loss of
Bcl-xL would result in cellular landscape changes in many
respects including the basal levels of mitochondrial fission
and fusion, bioenergetic capacity and membrane integrity.
Therefore, in this respect, the loss of the Drp1-Bcl-xL interaction
would be one of a myriad of landscape changes upon RNAi-
mediated depletion of Bcl-xL, and might not be the reason
underlying the cytoprotective effect. Moreover, RNAi-mediated
depletion of Bcl-xL does not affect the Drp1-Mff interaction
that is substantially responsible for Drp1 recruitment (Otera
et al., 2010; Loson et al., 2013) and is regulated by SENP3-
mediated deSUMOylation (Guo et al., 2017). However, a puzzle
remains as to the reason why in the absence of Bcl-xL, RNAi-
mediated SENP3 depletion does not appear to prevent cell
death evoked by reoxygenation following OGD. One plausible
explanation could be that changes caused by Bcl-xL loss
may offset the cytoprotective effect resulting from reduced
Mff-mediated Drp1 mitochondrial localization due to SENP3
knockdown in cells subjected to OGD plus reoxygenation.
In other words, in the OGD/reoxygenation model used in
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this study loss of Bcl-xL is, on one hand a benefit for cell
survival but, on the other hand might greatly affect unknown
component(s)/parameters/pathway(s) essential for the protective
effect of SENP3-mediated deSUMOylation.
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